Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Nobel lecture. Adventures and excursions in bioassay--the stepping stones to prostacyclin.

× No keyword cloud information.

125 in total

Review 1. Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2, and prostacyclin.

Authors: S Moncada; J R Vane
Journal: Pharmacol Rev Date: 1978-09 Impact factor: 25.468

2. Treatment of intermittent claudication. A reappraisal of the value of alpha-tocopherol.

Authors: A M BOYD; J MARKS
Journal: Angiology Date: 1963-04 Impact factor: 3.619

3. Studies on the role of lipoperoxides in human pathology. II. The presence of peroxidized lipids in the atherosclerotic aorta.

Authors: J GLAVIND; S HARTMANN; J CLEMMESEN; K E JESSEN; H DAM
Journal: Acta Pathol Microbiol Scand Date: 1952

4. Inhibition of polymorphonuclear leukocyte adherence by prostacyclin.

Authors: L A Boxer; J M Allen; M Schmidt; M Yoder; R L Baehner
Journal: J Lab Clin Med Date: 1980-05

5. The effect of infused prostacyclin in migraine and cluster headache.

Authors: R C Peatfield; M J Gawel; F C Rose
Journal: Headache Date: 1981-09 Impact factor: 5.887

6. Prevention of blockage of partially obstructed coronary arteries with prostacyclin correlates with inhibition of platelet aggregation.

Authors: J W Aiken; R R Gorman; R J Shebuski
Journal: Prostaglandins Date: 1979-04

7. Prostacyclin therapy in patients with congestive heart failure.

Authors: Y Yui; H Nakajima; C Kawai; T Murakami
Journal: Am J Cardiol Date: 1982-08 Impact factor: 2.778

8. Cyclic adenosine 3',5'-monophosphate inhibits the availability of arachidonate to prostaglandin synthetase in human platelet suspensions.

Authors: M Minkes; N Stanford; M M Chi; G J Roth; A Raz; P Needleman; P W Majerus
Journal: J Clin Invest Date: 1977-03 Impact factor: 14.808

9. Release of rabbit aorta contracting substance (RCS) and prostaglandins induced by chemical or mechanical stimulation of guinea-pig lungs.

Authors: M A Palmer; P J Piper; J R Vane
Journal: Br J Pharmacol Date: 1973-10 Impact factor: 8.739

10. Prostacyclin production by isolated adipocytes.

Authors: L Axelrod; L Levine
Journal: Diabetes Date: 1981-02 Impact factor: 9.461

6 in total

1. Pulmonary and haemodynamic effects of extracorporeal circulation in the cat and the beneficial effects of prostacyclin.

Authors: J Jahr; P O Grände
Journal: Intensive Care Med Date: 1992 Impact factor: 17.440

2. Prostacyclin counteracts the increase in capillary permeability induced by tumour necrosis factor-alpha.

Authors: J Jahr; P O Grände
Journal: Intensive Care Med Date: 1996-12 Impact factor: 17.440

3. Unlocking Aspirin's Chemopreventive Activity: Role of Irreversibly Inhibiting Platelet Cyclooxygenase-1.

Authors: Lenard M Lichtenberger; Dexing Fang; Roger J Bick; Brian J Poindexter; Tri Phan; Angela L Bergeron; Subhashree Pradhan; Elizabeth J Dial; K Vinod Vijayan
Journal: Cancer Prev Res (Phila) Date: 2016-12-20

4. Comparison between prostaglandin E1 and epoprostenol (prostacyclin) in infants after heart surgery.

Authors: J Kermode; W Butt; F Shann
Journal: Br Heart J Date: 1991-08

Review 5. COVID-19 is, in the end, an endothelial disease.

Authors: Peter Libby; Thomas Lüscher
Journal: Eur Heart J Date: 2020-09-01 Impact factor: 29.983

Review 6. Effects of prostaglandins and COX-inhibiting drugs on skeletal muscle adaptations to exercise.

Authors: Todd A Trappe; Sophia Z Liu
Journal: J Appl Physiol (1985) Date: 2013-03-28

6 in total